PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of chang
Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i
July 19, 2022 Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures
eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair
C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its
Diamyd Medical Joins International Consortium in Type 1 Diabetes TUCSON, Ariz., June 30, 2022 — Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the U
C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, a
C-Path Welcomes RWS C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
C-Path Welcomes Parexel C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri